Prolonged survival with longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma

BACKGROUND: Though lenalidomide maintenance therapy has demonstrated improved outcomes after autologous hematopoietic stem cell transplantation (auto-HCT) in patients with multiple myeloma (MM), the impact of the duration of this therapy is not clearly known. PATIENTS AND METHODS: We retrospectively...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer
Autori principali: Mian, Idrees, Milton, Denái R., Shah, Nina, Nieto, Yago, Popat, Uday R., Kebriaei, Partow, Parmar, Simrit, Oran, Betul, Shah, Jatin J., Manasanch, Elisabet E., Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H., Bashir, Qaiser
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5138119/
https://ncbi.nlm.nih.gov/pubmed/27680710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30366
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi